0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
NHS is set to offer a new drug, Abaloparatide, to help prevent bone fractures in postmenopausal women. This is expected to be available in 3 months, potentially benefiting over 14,000 women.
Share this article
If you liked this article share it with your friends.they will thank you later